Fifth Third Bancorp Merck & Co., Inc. Transaction History

Fifth Third Bancorp

$26.1 Billion
Q2 2024

A detailed history of Fifth Third Bancorp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 907,282 shares of MRK stock, worth $103 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

907,282

Previous 881,761 2.89%

Holding current value

$103 Million

Previous $116 Million 3.46%

% of portfolio

0.43%

Previous 0.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$123.8 - $132.96 $3.16 Million - $3.39 Million	25,521 Added 2.89%	907,282 $112 Million
Q1 2024 Apr 23, 2024	BUY	$113.24 - $131.95 $2.2 Million - $2.56 Million	19,407 Added 2.25%	881,761 $116 Million
Q4 2023 Jan 19, 2024	SELL	$100.18 - $109.02 $6.98 Million - $7.6 Million	-69,714 Reduced 7.48%	862,354 $94 Million
Q3 2023 Oct 31, 2023	SELL	$102.95 - $114.33 $1.44 Million - $1.6 Million	-13,955 Reduced 1.48%	932,068 $96 Million
Q2 2023 Jul 25, 2023	BUY	$108.61 - $118.38 $4.03 Million - $4.39 Million	37,121 Added 4.08%	946,023 $109 Million
Q1 2023 Apr 24, 2023	BUY	$102.94 - $114.86 $443,259 - $494,587	4,306 Added 0.48%	908,902 $96.7 Million
Q4 2022 Jan 25, 2023	BUY	$87.44 - $112.11 $4.1 Million - $5.25 Million	46,844 Added 5.46%	904,596 $0
Q3 2022 Oct 25, 2022	SELL	$84.53 - $94.96 $296,953 - $333,594	-3,513 Reduced 0.41%	857,752 $73.9 Million
Q2 2022 Aug 04, 2022	SELL	$83.49 - $94.64 $35,900 - $40,695	-430 Reduced 0.05%	861,265 $78.5 Million
Q1 2022 Apr 19, 2022	BUY	$73.51 - $82.4 $4.25 Million - $4.76 Million	57,764 Added 7.19%	861,695 $70.7 Million
Q4 2021 Feb 01, 2022	BUY	$72.28 - $90.54 $4.46 Million - $5.58 Million	61,647 Added 8.31%	803,931 $61.6 Million
Q3 2021 Oct 15, 2021	SELL	$71.68 - $78.83 $1.3 Million - $1.43 Million	-18,115 Reduced 2.38%	742,284 $55.8 Million
Q2 2021 Aug 06, 2021	SELL	$70.31 - $77.77 $388,743 - $429,990	-5,529 Reduced 0.72%	760,399 $59.1 Million
Q1 2021 May 07, 2021	SELL	$68.86 - $81.11 $4.61 Million - $5.43 Million	-66,940 Reduced 8.04%	765,928 $59 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $467,366 - $518,680	-6,512 Reduced 0.78%	832,868 $68.1 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $5.04 Million - $5.71 Million	68,895 Added 8.94%	839,380 $69.6 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $1.96 Million - $2.23 Million	27,862 Added 3.75%	770,485 $59.6 Million
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $1.32 Million - $1.82 Million	-20,774 Reduced 2.72%	742,623 $57.1 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $658,964 - $743,564	-8,494 Reduced 1.1%	763,397 $69.4 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $599,662 - $653,654	-7,882 Reduced 1.01%	771,891 $65 Million
Q2 2019 Aug 07, 2019	BUY	$69.84 - $81.59 $937,113 - $1.09 Million	13,418 Added 1.75%	779,773 $65.4 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $6.99 Million - $7.97 Million	100,450 Added 15.08%	766,355 $63.7 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $708,375 - $822,059	10,858 Added 1.66%	665,905 $50.9 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $259,893 - $305,619	-4,505 Reduced 0.68%	655,047 $46.5 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $2.09 Million - $2.45 Million	-41,072 Reduced 5.86%	659,552 $40 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $1.47 Million - $1.71 Million	-28,867 Reduced 3.96%	700,624 $38.2 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $3.02 Million - $3.6 Million	-58,421 Reduced 7.41%	729,491 $41 Million
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $1.18 Million - $1.27 Million	-20,113 Reduced 2.49%	787,912 $50.5 Million
Q2 2017 Aug 11, 2017	BUY	N/A	808,025	808,025 $51.8 Million

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Merck & Co., Inc. Transaction History